Ivanov Nikita

Ivanov Nikita

Education

Nikita Ivanov graduated from the Russian State Medical University with a degree in Medical Biochemistry and the Business School of the University of Antwerp (Belgium) with a diploma in the EMBA program.

Career

2005-2017

Nikita Ivanov began working at Pfizer in 2005 as a medical representative. He held various positions with an increasing level of responsibility and led a number of significant projects, including a project to optimize the company's business divisions.

In 2013, he began working at the company's regional office in New York, USA as a Business Operations and Strategy Manager. He was appointed to the position of Head of the Cluster of Developing and Developed Markets for Drugs of the Urology/Respiratory Diseases/Women's Health groups.

Until November 2017, Nikita Ivanov managed the Innovative Drugs business unit in Russia, and until recently headed the Rheumatology and Immunology division.

2022: Appointment as head of Pfizer's Russian office

At the end of May 2022, it became known about the appointment of Nikita Ivanov as the new head of the Russian office of Pfizer. He replaced Eric Patroyard, who headed Pfizer Innovations LLC (Pfizer's main legal entity in the Russian Federation) since 2017. His new job was not named by the end of May 2022.

By this time, Nikita Ivanov had been working at Pfizer for more than 16 years and held various positions in the company. Recently (before being appointed head of Pfizer Innovations LLC), he was Senior Director for Corporate Relations and Market Access at Pfizer in Russia and Belarus.

In mid-March 2022, Pfizer announced that it would continue to supply drugs to Russia. At the same time, the company will stop testing and recruiting patients for them in the country, and will also not invest in production facilities.^[1]

Notes

Шаблон:Remarks